Ciprofloxacin enhances stress erythropoiesis in spleen and increases survival after whole-body irradiation combined with skin-wound trauma.

Ciprofloxacin enhances stress erythropoiesis in spleen and increases survival after whole-body irradiation combined with skin-wound trauma.
复制标题

DOI:
10.1371/journal.pone.0090448
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Kiang JG
Kiang JG
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Fukumoto R;Burns TM;Kiang JG

文献摘要

参考文献

被引文献

相似文献

严重的造血功能丧失是放射复合伤(CI)后的主要治疗靶点之一。在这项研究中,我们测试了环丙沙星(CIP)作为一种治疗方法的使用,因为最近报道的针对CI的免疫调节作用可能会改善造血。CIP方案为每日1次口服,连续3周,首次给药时间为脑梗塞后2小时。CIP治疗提高了小鼠30天的存活率,与未经治疗的对照组的35%相比,提高了80%。对早期血液学参数变化的研究发现,CI诱导的进展性贫血持续10天,CIP显著改善。CI诱导肾脏促红细胞生成素(EPO)基因表达,肾脏和血清蛋白表达,CIP刺激EPO基因表达。在CI小鼠的脾中,CIP通过EPO受体诱导巨噬细胞表达骨形态发生蛋白4(BMP4)。经CIP处理的CI小鼠脾细胞形成CD71+集落形成单位红系明显好于对照组。因此,CIP介导的BMP4依赖的应激性红细胞生成可能在提高脑梗塞后的存活率中发挥作用。
Severe hematopoietic loss is one of the major therapeutic targets after radiation-combined injury (CI), a kind of injury resulting from radiation exposure combined with other traumas. In this study, we tested the use of ciprofloxacin (CIP) as a treatment, because of recently reported immunomodulatory effects against CI that may improve hematopoiesis. The CIP regimen was a daily, oral dose for 3 weeks, with the first dose 2 h after CI. CIP treatment improved 30-day survival in mice at 80% compared to 35% for untreated controls. Study of early changes in hematological parameters identified CI-induced progressive anemia by 10 days that CIP significantly ameliorated. CI induced erythropoietin (EPO) mRNA in kidney and protein in kidney and serum; CIP stimulated EPO mRNA expression. In spleens of CI mice, CIP induced bone morphogenetic protein 4 (BMP4) in macrophages with EPO receptors. Splenocytes from CIP-treated CI mice formed CD71+ colony-forming unit-erythroid significantly better than those from controls. Thus, CIP-mediated BMP4-dependent stress erythropoiesis may play a role in improving survival after CI.
DOI: 10.1371/journal.pone.0058389
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Fukumoto R;Cary LH;Gorbunov NV;Lombardini ED;Elliott TB;Kiang JG
通讯作者: Kiang JG
DOI: 10.1038/nm.3057
发表时间: 2013-04
期刊: Nature medicine
影响因子: 82.9
作者:
通讯作者: --
DOI: 10.1056/nejm199907293410501
发表时间: 1999-07-29
影响因子: 158.5
作者:
Freifeld, A;Marchigiani, D;Pizzo, PP
通讯作者: Pizzo, PP
DOI: 10.1186/2045-3701-2-20
发表时间: 2012-06-11
影响因子: 7.5
作者:
Kiang, Juliann G.;Garrison, Bradley R.;Ledney, G. David
通讯作者: Ledney, G. David
DOI: 10.1182/blood-2008-12-195651
发表时间: 2009-05-21
期刊: BLOOD
影响因子: 20.3
作者:
Theurl, Igor;Aigner, Elmar;Weiss, Guenter
通讯作者: Weiss, Guenter